About half of mice with heterozygous deletion of ELF developed hepatocellular carcinoma, and 90% of ELF+/−/Smad4+/− mice developed gastric cancer and other gastrointestinal cancers [23,24]. The gene discussed is SPTBN1; the disease is hepatocellular carcinoma.